These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 23262384

  • 1. Preparation and hydrolytic erosion of differently structured PLGA nanoparticles with chitosan modification.
    Ma FK, Li J, Kong M, Liu Y, An Y, Chen XG.
    Int J Biol Macromol; 2013 Mar; 54():174-9. PubMed ID: 23262384
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q.
    Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815
    [Abstract] [Full Text] [Related]

  • 3. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C, Seo J, Hwang HS, Thao LQ, Lee S, Lee ES, Lee EH, Choi HG, Youn YS.
    Biomed Pharmacother; 2016 Mar 21; 78():226-233. PubMed ID: 26898446
    [Abstract] [Full Text] [Related]

  • 4. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW, Wang SS, Tsai WJ.
    Biomaterials; 2008 Jan 21; 29(2):228-37. PubMed ID: 17953984
    [Abstract] [Full Text] [Related]

  • 5. Chitosan-poly (lactide-co-glycolide) (CS-PLGA) nanoparticles containing metformin HCl: preparation and in vitro evaluation.
    Gundogdu N, Cetin M.
    Pak J Pharm Sci; 2014 Nov 21; 27(6):1923-9. PubMed ID: 25362616
    [Abstract] [Full Text] [Related]

  • 6. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N, Jackson TL, Elsaid Z, Alqathama A, Somavarapu S.
    Mol Pharm; 2016 Sep 06; 13(9):2923-40. PubMed ID: 27286558
    [Abstract] [Full Text] [Related]

  • 7. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176
    [Abstract] [Full Text] [Related]

  • 8. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
    Lee SY, Jung E, Park JH, Park JW, Shim CK, Kim DD, Yoon IS, Cho HJ.
    J Colloid Interface Sci; 2016 Oct 15; 480():102-108. PubMed ID: 27421112
    [Abstract] [Full Text] [Related]

  • 9. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, Youn YS.
    Int J Nanomedicine; 2013 Oct 15; 8():2975-83. PubMed ID: 23976850
    [Abstract] [Full Text] [Related]

  • 10. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D, Mangal S, Goswami R, Jaganathan KS.
    Eur J Pharm Biopharm; 2013 Nov 15; 85(3 Pt A):550-9. PubMed ID: 23831265
    [Abstract] [Full Text] [Related]

  • 11. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J, Chen JY, Liu J, Luo M, Wang YJ, Wei XW, Gao X, Wang BL, Liu YB, Yi T, Tong AP, Song XR, Xie YM, Zhao Y, Xiang M, Huang Y, Zheng Y.
    Int J Pharm; 2012 Jul 15; 431(1-2):210-21. PubMed ID: 22561795
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.
    Chronopoulou L, Massimi M, Giardi MF, Cametti C, Devirgiliis LC, Dentini M, Palocci C.
    Colloids Surf B Biointerfaces; 2013 Mar 01; 103():310-7. PubMed ID: 23261553
    [Abstract] [Full Text] [Related]

  • 14. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y, Xie XY, Mei XG.
    Drug Deliv; 2016 Mar 01; 23(3):787-93. PubMed ID: 24870204
    [Abstract] [Full Text] [Related]

  • 15. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P, Xu Y, Zeng C, Ren H, Peng M.
    Int J Pharm; 2011 Aug 30; 415(1-2):259-66. PubMed ID: 21645597
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J, Han L, Qin J, Ru G, Li R, Wu L, Cui D, Yang P, He Y, Wang J.
    ACS Appl Mater Interfaces; 2015 Jul 22; 7(28):15430-41. PubMed ID: 26111015
    [Abstract] [Full Text] [Related]

  • 20. Chemico-physical investigation of tenofovir loaded polymeric nanoparticles.
    Belletti D, Tosi G, Forni F, Gamberini MC, Baraldi C, Vandelli MA, Ruozi B.
    Int J Pharm; 2012 Oct 15; 436(1-2):753-63. PubMed ID: 22884838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.